Scleroderma: Stem Cell Injections for Digital Ulcers

We are studying if injections of cultured fat cells can help heal stubborn digital ulcers in patients with scleroderma. This trial compares the treatment to a placebo to evaluate its effectiveness and safety.

>2 years6-10 visitsEfficacy phase (II)Cost ReimbursementInvestigational MedicinesInjectionInternal MedicineRheumatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Human Serum Albumin
Human serum albumin is a blood protein used to restore blood volume and maintain blood pressure after severe fluid loss or low albumin levels.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

CellReady
Allogenic Adipose-Tissue-Derived Mesenchymal Stem Cells

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Centre Hospitalier Universitaire De Lille
Internal medicine
La Madeleine, France
Centre Hospitalier Universitaire Grenoble Alpes
vascular medicine
La Tronche, France
Centre Hospitalier Universitaire De Montpellier
Internal medicine
Montpellier, France
Sponsor: Centre Hospitalier Universitaire De Toulouse
Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.